Glen C. MacDonald
Chief Executive Officer chez Leucadia Finance Partners, Inc.
Fortune : 45 277 $ au 31/03/2024
Postes actifs de Glen C. MacDonald
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Leucadia Finance Partners, Inc.
 Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Leucadia Finance Partners, Inc. provides investment services. The company was founded on January 12, 2014 and is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| President | - | - |
Historique de carrière de Glen C. MacDonald
Anciens postes connus de Glen C. MacDonald
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Viventia Bio, Inc.
 Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/09/2016 |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Chief Tech/Sci/R&D Officer | 01/01/1997 | 01/01/2012 |
| CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 21/09/2016 | - |
| Princess Margaret Hospital Foundation | Corporate Officer/Principal | - | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
Formation de Glen C. MacDonald
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Statistiques
Internationale
| Canada | 7 |
| Etats-Unis | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Leucadia Finance Partners, Inc. provides investment services. The company was founded on January 12, 2014 and is headquartered in Vancouver, Canada. | Finance |
| Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |
- Bourse
- Insiders
- Glen C. MacDonald
- Expérience
